Stay updated with breaking news from Cell Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine.
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.
Researchers announced earlier this month that they had found a link between a western diet and cognitive decline and neurodegeneration in a study using mice.
Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.
Iron Age Europeans enjoyed foods that are still part of our diet today, including blue cheese and beer, new research studying ancient poop has shown.